Skip to main content

Advertisement

SpringerLink
Log in

Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide

  • Research Article
  • Published:
Tumor Biology

Abstract

Nitric oxide (NO), a free radical, has been implicated in the biology of human cancers, including breast cancer, yet it is still unclear how NO affects tumor development and propagation. We herein gradually adapted four human breast adenocarcinoma cell lines (BT-20, Hs578T, T-47D, and MCF-7) to increasing concentrations of the NO donor DETA-NONOate up to 600 μM. The resulting model system consisted of a set of fully adapted high nitric oxide (“HNO”) cell lines that are biologically different from the “parent” cell lines from which they originated. Although each of the four parent and HNO cell lines had identical morphologic appearance, the HNO cells grew faster than their corresponding parent cells and were resistant to both nitrogen- and oxygen-based free radicals. These cell lines serve as a novel tool to study the role of NO in breast cancer progression and potentially can be used to predict the therapeutic response leading to more efficient therapeutic regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. U.S. Cancer Statistics Working Group, United states cancer statistics: 1999-2005 incidence and mortality web-based report. (2009) http://www.cdc.gov./uscs, Accessed May 14, 2009.

  2. Gonzalez-Anqulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22.

    Article  Google Scholar 

  3. Yamaguchi Y, Hayashi S. Estrogen-related cancer microenvironment of breast carcinoma. Endocr J. 2009;56:1–7.

    Article  PubMed  Google Scholar 

  4. Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, et al. Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC Cancer. 2008;8:364.

    Article  PubMed  Google Scholar 

  5. Radisky ES, Radisky DC. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord. 2007;8:279–87.

    Article  PubMed  Google Scholar 

  6. Bentz BG, Haines III GK, Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carcinoma. Head Neck. 2000;22:64–70.

    Article  CAS  PubMed  Google Scholar 

  7. Hibbs JB, Vavrin A, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987;138:550–65.

    CAS  PubMed  Google Scholar 

  8. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995;92:4392–6.

    Article  CAS  PubMed  Google Scholar 

  9. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med. 2008;45:18–31.

    Article  CAS  PubMed  Google Scholar 

  10. Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, et al. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci USA. 2004;101:8894–9.

    Article  CAS  PubMed  Google Scholar 

  11. Zhou J, Schmid T, Brune B. HIF-1alpha and p53 as targets of NO in affecting cell proliferation, death and adaptation. Curr Mol Med. 2004;4:741–51.

    Article  CAS  PubMed  Google Scholar 

  12. Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, et al. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide. 2008;19:73–6.

    Article  CAS  PubMed  Google Scholar 

  13. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8:1329–37.

    Article  CAS  PubMed  Google Scholar 

  14. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med. 1998;25:434–56.

    Article  CAS  PubMed  Google Scholar 

  15. Bentz BG, Haines III GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue. Head Neck. 1998;20:304–9.

    Article  CAS  PubMed  Google Scholar 

  16. Bentz BG, Haines III GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108:781–7.

    CAS  PubMed  Google Scholar 

  17. Chandra R, Haines III GK, Bentz BG, Shah P, Robinson AM, Radosevich JA. Expression of nitric oxide synthase type 3 in reflux-induced esophageal lesions. Otolaryngol Head Neck Surg. 2001;124:442–7.

    Article  CAS  PubMed  Google Scholar 

  18. Chen HHW, Su W-C, Chou C-Y, Guo H-R, Ho S-Y, Que J, et al. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:1093–100.

    Article  CAS  PubMed  Google Scholar 

  19. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1994;55:727–30.

    Google Scholar 

  20. Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, et al. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn J Cancer Res. 1998;89:696–702.

    CAS  PubMed  Google Scholar 

  21. Gavilanes J, Moro MA, Lizasoain I, Lorenzo P, Perez A, Leza JC, et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope. 1999;109:148–52.

    Article  CAS  PubMed  Google Scholar 

  22. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer. 1998;78:534–41.

    CAS  PubMed  Google Scholar 

  23. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer. 1998;82:1897–903.

    Article  CAS  PubMed  Google Scholar 

  24. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res. 2000;6:4739–44.

    CAS  PubMed  Google Scholar 

  25. Thomsen LL, Farais-Eisner R, Chaudhuri G. Nitric oxide: Role in human cervical cancer. In: Moncada S, Stamler J, Gross S, Higgs EA, editors. The biology of nitric oxide part 5. Proceedings of the 4th international meeting on the biology of nitric oxide. London: Portland Press; 1996. p. 289.

    Google Scholar 

  26. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase in human breast cancer. Br J Cancer. 1995;72:41–4.

    CAS  PubMed  Google Scholar 

  27. Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, et al. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-c and correlation with metastasis and poor prognosis. Clin Cancer Res. 2006;12:1201–7.

    Article  CAS  PubMed  Google Scholar 

  28. Glynn S, Boersma B, Martin D, Howe L, Ridnour L, Wink D, et al. iNOS expression is associated with basal-like breast cancer phenotype and predicts poor survival in ERneg breast cancer. Nitric Oxide. 2007;17:S17.

    Article  Google Scholar 

  29. Duenas-Gonzalez A, Isales CM, del Mar Abad-Hernandez M, Gonzalez-Sarmiento R, Sangueza O, Rodriguez-Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod Pathol. 1997;10:645–9.

    CAS  PubMed  Google Scholar 

  30. Bulut AS, Erden E, Sak SD, Doruk H, Kursun N, Dincol D. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Virchows Arch. 2005;447:24–30.

    Article  CAS  PubMed  Google Scholar 

  31. Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, et al. The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur J Cancer. 2005;41:265–71.

    Article  CAS  PubMed  Google Scholar 

  32. Radosevich JA, Elseth KM, Vesper BJ, Tarjan G, Haines III GK. Long-term adaptation of lung tumor cell lines with increasing concentrations of nitric oxide donor. The Open Lung Cancer Journal. 2009;2:35–44.

    Article  CAS  Google Scholar 

  33. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, et al. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst. 1977;58:1795–806.

    CAS  PubMed  Google Scholar 

  34. Lasfargues EY, Ozzello L. Cultivation of human breast carcinomas. J Natl Cancer Inst. 1958;21:1131–47.

    CAS  PubMed  Google Scholar 

  35. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51:1409–16.

    CAS  PubMed  Google Scholar 

  36. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, et al. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979;15:659–70.

    CAS  PubMed  Google Scholar 

  37. Bentz BG, Hammer ND, Milash B, Klein S, Burnett DM, Radosevich JA, et al. The kinetics and redox state of nitric oxide determine the biological consequences in lung adenocarcinoma. Tumor Biol. 2007;28:301–11.

    Article  CAS  Google Scholar 

  38. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, Kokubo T, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 1997;57:5386–90.

    CAS  PubMed  Google Scholar 

  39. Smith HS. In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue. J Natl Cancer Inst. 1979;62:225–30.

    CAS  PubMed  Google Scholar 

  40. Castles CG, Fuqua SA, Klotz DM, Hill SM. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 1993;53:5934–9.

    CAS  PubMed  Google Scholar 

  41. Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 1994;54:2615–21.

    CAS  PubMed  Google Scholar 

  42. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino Jr MA, Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985;230:943–5.

    Article  CAS  PubMed  Google Scholar 

  43. Poutanen M, Moncharmont B, Vihko R. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res. 1992;52:290–4.

    CAS  PubMed  Google Scholar 

  44. Brandes LJ, Hermonat MW. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol. Cancer Res. 1983;43:2831–5.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a VA Merit Review Grant (J.A.R.).

Author information

Authors and Affiliations

  1. Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, 801 S. Paulina St., Chicago, IL, 60612, USA

    Benjamin J. Vesper, Kim M. Elseth & James A. Radosevich

  2. Jesse Brown VAMC, Chicago, IL, 60612, USA

    Benjamin J. Vesper, Kim M. Elseth & James A. Radosevich

  3. Department of Pathology, John H. Stroger, Jr Hospital of Cook County, Chicago, IL, 60612, USA

    Gabor Tarjan

  4. Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA

    G. Kenneth Haines III

Authors
  1. Benjamin J. Vesper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim M. Elseth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabor Tarjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Kenneth Haines III
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. James A. Radosevich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James A. Radosevich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vesper, B.J., Elseth, K.M., Tarjan, G. et al. Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide. Tumor Biol. 31, 267–275 (2010). https://doi.org/10.1007/s13277-010-0028-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-010-0028-6

Keywords

Search

Navigation